Literature DB >> 21735469

Fine phenotypic and functional characterization of effector cluster of differentiation 8 positive T cells in human patients with primary biliary cirrhosis.

Masanobu Tsuda1, Yoko M Ambrosini, Weici Zhang, Guo-Xiang Yang, Yugo Ando, Guanghua Rong, Koichi Tsuneyama, Kosuke Sumida, Shinji Shimoda, Christopher L Bowlus, Patrick S C Leung, Xiao-Song He, Ross L Coppel, Aftab A Ansari, Zhe-Xiong Lian, M Eric Gershwin.   

Abstract

UNLABELLED: In primary biliary cirrhosis (PBC), patients develop a multilineage response to a highly restricted peptide of the E2 component of pyruvate dehydrogenase (PDC-E2) involving autoantibody and autoreactive cluster of differentiation (CD)4(+) and CD8(+) T-cell responses. Recent data from murine models have suggested that liver-infiltrating CD8(+) cells play a critical role in biliary destruction in PBC. We hypothesized that chronic antigen stimulation of CD8(+) T cells alters effector memory T cell (T(EM) ) frequency and function similar to that seen with chronic viral infections, including failure to terminally differentiate and relative resistance to apoptosis. We have rigorously phenotyped CD8(+) T-cell subpopulations from 132 subjects, including 76 patients with PBC and 56 controls, and report a higher frequency of T(EM) cells characterized as CD45RO(high) CD57(+) CD8(high), but expressing the gut homing integrin, α4β7, in peripheral blood mononuclear cells of PBC. These CD8(high) T(EM) cells have reduced expression of Annexin V after TCR stimulation. Consistent with a T(EM) phenotype, CD45RO(high) CD57(+) CD8(high) T cells express higher levels of granzyme A, granzyme B, perforin, CCR5 and α4β7, and lower levels of CCR7 and CD28 than other CD8(high) T cells. Furthermore, interleukin (IL)-5 produced by CD8(+) CD57(+) T lymphocytes upon in vitro T-cell receptor stimulation are increased in PBC. Histologically, CD8(+) CD57(+) T cells accumulate around the portal area in PBC. Moreover, CD8(+) CD57(+) T cells respond specifically to the major histocompatibility class I epitope of PDC-E2.
CONCLUSION: In conclusion, our data demonstrate that CD45RO(high) CD57(+) CD8(high) T cells are a subset of terminally differentiated cytotoxic T(EM) cells, which could play a critical role in the progressive destruction of biliary epithelial cells.
Copyright © 2011 American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21735469      PMCID: PMC3184190          DOI: 10.1002/hep.24526

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  47 in total

Review 1.  Sidechain biology and the immunogenicity of PDC-E2, the major autoantigen of primary biliary cirrhosis.

Authors:  Tin K Mao; Paul A Davis; Joseph A Odin; Ross L Coppel; M Eric Gershwin
Journal:  Hepatology       Date:  2004-12       Impact factor: 17.425

Review 2.  The immunobiology of primary sclerosing cholangitis.

Authors:  Christopher A Aoki; Christopher L Bowlus; M Eric Gershwin
Journal:  Autoimmun Rev       Date:  2005-03       Impact factor: 9.754

3.  Characterization of a cytotoxic CD57+ T cell subset from patients with pulmonary tuberculosis.

Authors:  I Sada-Ovalle; L Torre-Bouscoulet; R Valdez-Vázquez; S Martínez-Cairo; E Zenteno; R Lascurain
Journal:  Clin Immunol       Date:  2006-10-10       Impact factor: 3.969

4.  Changes in natural killer cells, the CD57CD8 subset, and related cytokines in healthy aging.

Authors:  S E McNerlan; I M Rea; H D Alexander; T C Morris
Journal:  J Clin Immunol       Date:  1998-01       Impact factor: 8.317

5.  Active participation of CCR5(+)CD8(+) T lymphocytes in the pathogenesis of liver injury in graft-versus-host disease.

Authors:  M Murai; H Yoneyama; A Harada; Z Yi; C Vestergaard; B Guo; K Suzuki; H Asakura; K Matsushima
Journal:  J Clin Invest       Date:  1999-07       Impact factor: 14.808

6.  Cutting Edge: Programmed death (PD) ligand-1/PD-1 interaction is required for CD8+ T cell tolerance to tissue antigens.

Authors:  Natalia Martin-Orozco; Yi-Hong Wang; Hideo Yagita; Chen Dong
Journal:  J Immunol       Date:  2006-12-15       Impact factor: 5.422

7.  IL-2 receptor alpha(-/-) mice and the development of primary biliary cirrhosis.

Authors:  Kanji Wakabayashi; Zhe-Xiong Lian; Yuki Moritoki; Ruth Y Lan; Koichi Tsuneyama; Ya-Hui Chuang; Guo-Xiang Yang; William Ridgway; Yoshiyuki Ueno; Aftab A Ansari; Ross L Coppel; Ian R Mackay; M Eric Gershwin
Journal:  Hepatology       Date:  2006-11       Impact factor: 17.425

8.  Pars planitis is associated with an increased frequency of effector-memory CD57+ T cells.

Authors:  Miguel Pedroza-Seres; Marisela Linares; Stephanie Voorduin; Rojas-Ramos Enrique; Ricardo Lascurain; Yonathan Garfias; Maria Carmen Jimenez-Martinez
Journal:  Br J Ophthalmol       Date:  2007-05-02       Impact factor: 4.638

9.  Elevations in IFN-gamma, IL-5, and IL-10 in patients with the autoimmune disease primary biliary cirrhosis: association with autoantibodies and soluble CD30.

Authors:  S M Krams; S Cao; M Hayashi; J C Villanueva; O M Martinez
Journal:  Clin Immunol Immunopathol       Date:  1996-09

10.  Dysregulation of CD95/CD95 ligand-apoptotic pathway in CD3(+) large granular lymphocyte leukemia.

Authors:  T Lamy; J H Liu; T H Landowski; W S Dalton; T P Loughran
Journal:  Blood       Date:  1998-12-15       Impact factor: 22.113

View more
  23 in total

1.  Aberrant TGF-β1 signaling contributes to the development of primary biliary cirrhosis in murine model.

Authors:  Bin Liu; Xuan Zhang; Feng-Chun Zhang; Jin-Bao Zong; Wen Zhang; Yan Zhao
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

2.  Etiopathogenesis of primary biliary cirrhosis: an overview of recent developments.

Authors:  Palak J Trivedi; Sue Cullen
Journal:  Hepatol Int       Date:  2012-03-20       Impact factor: 6.047

Review 3.  The immunophysiology and apoptosis of biliary epithelial cells: primary biliary cirrhosis and primary sclerosing cholangitis.

Authors:  Kazuhito Kawata; Yoshimasa Kobayashi; M Eric Gershwin; Christopher L Bowlus
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

4.  Chronic expression of interferon-gamma leads to murine autoimmune cholangitis with a female predominance.

Authors:  Heekyong R Bae; Patrick S C Leung; Koichi Tsuneyama; Julio C Valencia; Deborah L Hodge; Seohyun Kim; Tim Back; Megan Karwan; Anand S Merchant; Nobuyuki Baba; Dechun Feng; Ogyi Park; Bin Gao; Guo-Xiang Yang; M Eric Gershwin; Howard A Young
Journal:  Hepatology       Date:  2016-06-15       Impact factor: 17.425

Review 5.  Primary biliary cholangitis: pathogenesis and therapeutic opportunities.

Authors:  Aliya F Gulamhusein; Gideon M Hirschfield
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2019-12-09       Impact factor: 46.802

Review 6.  Role of autoimmunity in primary biliary cirrhosis.

Authors:  Tian-Yan Shi; Feng-Chun Zhang
Journal:  World J Gastroenterol       Date:  2012-12-28       Impact factor: 5.742

7.  Murine autoimmune cholangitis requires two hits: cytotoxic KLRG1(+) CD8 effector cells and defective T regulatory cells.

Authors:  Wenting Huang; Kritika Kachapati; David Adams; Yuehong Wu; Patrick S C Leung; Guo-Xiang Yang; Weici Zhang; Aftab A Ansari; Richard A Flavell; M Eric Gershwin; William M Ridgway
Journal:  J Autoimmun       Date:  2014-02-18       Impact factor: 7.094

8.  Proteomic analysis reveals distinctive protein profiles involved in CD8+ T cell-mediated murine autoimmune cholangitis.

Authors:  Weici Zhang; Ren Zhang; Jun Zhang; Ying Sun; Patrick Sc Leung; Guo-Xiang Yang; Zongwen Shuai; William M Ridgway; M Eric Gershwin
Journal:  Cell Mol Immunol       Date:  2018-01-29       Impact factor: 11.530

Review 9.  Mechanisms of tissue injury in autoimmune liver diseases.

Authors:  Evaggelia Liaskou; Gideon M Hirschfield; M Eric Gershwin
Journal:  Semin Immunopathol       Date:  2014-08-01       Impact factor: 9.623

Review 10.  Epigenetics and Primary Biliary Cirrhosis: a Comprehensive Review and Implications for Autoimmunity.

Authors:  Yu-Qing Xie; Hong-Di Ma; Zhe-Xiong Lian
Journal:  Clin Rev Allergy Immunol       Date:  2016-06       Impact factor: 8.667

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.